Jiang et al. confirmed that mTOR can promote the upregulation of Bcl-2 and enhance cell survival; in contrast, it inhibits Bcl-2 expression, reduces the cell survival rate, and promotes cell apoptosis in CRC [26]. Here, BCL2 is linked to colorectal carcinoma.